Pharmacielo Ltd
XTSX:PCLO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pharmacielo Ltd
Cash from Operating Activities
Pharmacielo Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharmacielo Ltd
XTSX:PCLO
|
Cash from Operating Activities
-CA$1m
|
CAGR 3-Years
53%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Operating Activities
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
-5%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Operating Activities
-CA$78.7m
|
CAGR 3-Years
48%
|
CAGR 5-Years
33%
|
CAGR 10-Years
-18%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Operating Activities
$25.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash from Operating Activities
-$113.9m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-117%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Operating Activities
CA$69m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
25%
|
|
Pharmacielo Ltd
Glance View
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The Company’s principal subsidiary includes PharmaCielo Colombia Holdings S.A.S. The company produces non-psychoactive and psychoactive extracts. Its psychoactive product line is designed and formulated to meet the needs of the medical industry. Its psychoactive products include THC Distillate and THC:CBD Standardized Oil. Its non-psychoactive products are designed to meet the needs of clients in the medical, nutraceutical and wellness industries. Its non-psychoactive products include Broad-Spectrum Distillate Standardized Oil, CBD Isolate, Broad-Spectrum Distillate, Broad-Spectrum Oil, Water-Soluble CBD, CBD Standardized Oil and Full-Spectrum Standardized Oil.
See Also
What is Pharmacielo Ltd's Cash from Operating Activities?
Cash from Operating Activities
-1m
CAD
Based on the financial report for Dec 31, 2025, Pharmacielo Ltd's Cash from Operating Activities amounts to -1m CAD.
What is Pharmacielo Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
46%
Over the last year, the Cash from Operating Activities growth was 48%. The average annual Cash from Operating Activities growth rates for Pharmacielo Ltd have been 53% over the past three years , 46% over the past five years .
